Latikafusp represents a novel therapeutic strategy for managing particular tumors, particularly those involving aberrant ALK proteins. This agent functions as an blocker of altered ALK structures, demonstrating promise https://matteoqmwk735116.wikicorrespondence.com/6673450/latikafusp_a_new_treatment_strategy